WCG Clinical

OCTOBER 9, 2023

The dermatology market is embarking on tremendous growth and sponsors need to be ready. Over the last 12 months, dermatology-focused studies have increased by roughly 20%, with top focus areas including psoriasis, atopic dermatitis, and alopecia. This rapid growth brings new challenges. Efficiency and speed are critical.

Dermatology 59

Dermatology Trials Marketing Clinical Trials 59

WCG Clinical

SEPTEMBER 20, 2023

Welcome to the recorded session of ‘Optimizing Endpoint Assessments for Dermatology Studies.’ In this insightful webinar, we take a deep dive into dermatology trials and discuss how standardizing rater qualification and training can solve common challenges and protect the quality and integrity of endpoint data.

Dermatology 52

Dermatology Trials Development Clinical Trials 52

Pharma Times

MARCH 10, 2023

Collaboration will concentrate on launching and running studies within medical dermatology

Clinical Trials 106

Clinical Trials Clinical Trials Dermatology Trials 106

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

WCG Clinical

MARCH 30, 2023

Uniform Live Action Training Using InvestigatorSpace Speeds Up Study Start Times In one case, a global pharmaceutical company used WCG’s training solutions to support two dermatology studies they were running. Study teams engaged with the training content throughout the trial and asked questions through the InvestigatorSpace platform.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Trials 52

XTalks

NOVEMBER 7, 2024

Emrosi’s approval was based on data from a pair of Phase III clinical trials for the treatment of rosacea. The trials met all co-primary and secondary endpoints, with participants having successfully completed the 16-week treatment with no significant safety issues.

FDA Approval 100

FDA Approval Dermatology Bacteria Clinical Trials 100

Pharmaceutical Commerce

JANUARY 16, 2024

Zoryve (roflumilast) shows efficacy in seborrheic dermatitis and atopic dermatitis in clinical trials.

Dermatology 52

Dermatology Trials Clinical Trials Clinical Trials 52

Olympian Clinical Research

FEBRUARY 26, 2021

Clinical trials are research studies designed to evaluate or test a medical, surgical, or behavioral intervention. Most recently, clinical trials have gained recognition through the development and testing of Covid-19 vaccines. Today we’re taking some time to highlight a few of the biggest ones!

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

STAT News

DECEMBER 2, 2022

And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Dermatology 98

Outsourcing Pharma

FEBRUARY 2, 2021

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

Clinical Trials 63

Clinical Trials Clinical Trials Dermatology Trials 63

Rethinking Clinical Trials

SEPTEMBER 24, 2024

Mirza, MD, MPH Chief Resident Department of Dermatology Warren Alpert Medical School of Brown University Slides Keywords Artificial Intelligence; ChatGPT; Informed Consent Key Points Artificial Intelligence (AI), when implemented thoughtfully in clinical settings, can lead to meaningful results for patients.

Clinical Trials 130

Clinical Trials Clinical Trials Dermatology Trials 130

XTalks

SEPTEMBER 30, 2024

Presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, the study highlighted significant improvements in key disease markers, positioning orismilast as a potential breakthrough in atopic dermatitis management.

Clinical Trials 90

Clinical Trials Clinical Trials Dermatology Trials 90

XTalks

AUGUST 2, 2024

These trials reveal nemolizumab’s potential to significantly improve key aspects of atopic dermatitis, including skin lesions, itch and sleep disturbance, in both adolescent and adult patients with moderate-to-severe cases.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Licensing 52

XTalks

AUGUST 2, 2023

Eichenfield was also the principal investigator on clinical trials evaluating YCANTH. Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

Delveinsight

SEPTEMBER 28, 2021

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China. Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and commercialize Orismilast , a next-generation PDE4 inhibitor for inflammatory dermatology conditions in China.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Dermatology 80

FDA Law Blog

NOVEMBER 10, 2024

Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field. In October, FDA announced seven new clinical trial grants awarded in fiscal year (FY) 2024 – including one for a Phase 3 trial – totaling $17.2

Production 67

Production Clinical Development Development Regulation 67

Pharmaceutical Technology

APRIL 17, 2023

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. QPS was established in 1995 to provide bioanalytical LC-MS/MS contract services.

Dermatology 130

Dermatology Clinical Trials Clinical Trials Production 130

Scienmag

MAY 21, 2021

The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021). Results of the clinical trial at […].

Clinical Trials 43

Clinical Trials Clinical Trials Trials Research 43

Pharmaceutical Technology

JULY 12, 2022

A validated target in dermatology, PDE4 is an enzyme that induces overactive immune responses. The NDS submission by Arcutis is based on positive findings from the company’s pivotal Phase III programme and two long-term open-label clinical trials. Health Canada has provided a target action date of 30 April next year.

Dermatology 162

Dermatology Immune Response Trials Clinical Trials 162

XTalks

OCTOBER 24, 2024

In this blog, we break down some of the latest innovations in psoriasis treatment, including biosimilars, AI-driven diagnostics and the growing role of family care.

Research 100

Research Dermatology Clinical Trials Clinical Trials 100

Pharmaceutical Technology

MAY 19, 2023

Clinical response was observed after just two weeks in some cases. The FDA nod means Rinvoq is now approved for seven indications in gastroenterology, rheumatology and dermatology. A maintenance study showed the same effects at 52 weeks. In patients with severe symptoms, a dosage of 30mg can be considered.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264

XTalks

APRIL 17, 2023

In clinical trials, patients experienced significantly clearer skin and less interference with sleep due to itch when taking lebrikizumab compared to placebo. The ADvocate1 and ADvocate2 Phase III studies were published in the New England Journal of Medicine and the British Journal of Dermatology , respectively.

Dermatology 87

Dermatology Antibody Clinical Trials Clinical Trials 87

Pharmaceutical Technology

FEBRUARY 28, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

pharmaphorum

JULY 5, 2022

Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. With more than 500 dermatology clinical trials currently underway, it is often heard that there is a ‘’competition for participants’’. Patient recruitment for moderate or severe atopic dermatitis.

Trials 118

Trials Clinical Trials Clinical Trials Dermatology 118

Cloudbyz

AUGUST 7, 2024

Economic recessions cut across many industries; the clinical trials sector is no different. As with most other sectors, the recession puts pressure on the clinical trials to remain innovative yet maintain patient care at the forefront while operating within financial restrictions. Rare disease trials decreased by 30%.

Clinical Research 52

Clinical Research Clinical Trials Clinical Trials Research 52

The Pharma Data

OCTOBER 29, 2020

30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT ® ) will be presented at the annual Fall Clinical Dermatology meeting taking place virtually October 29-November 1, 2020. 10x ULN were observed in patients in Olumiant clinical trials.

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

Pharma Marketing Network

APRIL 30, 2021

Clinical trials may be one of the very last bastions of a non-customer-focused approach within the pharmaceutical industry. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials. How do we increase the diversity of clinical trials?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

JUNE 20, 2022

The results of their Phase IIa STP705 clinical study were published in the Journal of Drugs in Dermatology , a peer-reviewed medical journal of dermatology that was established in 2002. Clinical Trial Outcomes of isSCC Treatment with STP705. STP705 — A Promising siRNA Candidate Against isSCC.

RNA 84

RNA Clinical Trials Clinical Trials Dermatology 84

XTalks

APRIL 26, 2023

Clinical Performance of Novel Elastic Scattering Spectroscopy (ESS) in Detection of Skin Cancer: A Blinded, Prospective, Multi-Center Clinical Trial [Initial Results]. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022. Dermatology. Dermatology. 2004;208:27-31.

Life Science 52

Life Science Dermatology Clinical Trials Clinical Trials 52

XTalks

JUNE 26, 2024

Hyperhidrosis is the third most prevalent dermatological condition in the US, affecting roughly 15.3 While Sofdra stands out as the first new chemical entity approved for primary axillary hyperhidrosis, the market for hyperhidrosis treatments includes other medications and clinical trials.

Clinical Trials 92

Clinical Trials Clinical Trials Dermatology FDA Approval 92

Pharmaceutical Technology

FEBRUARY 28, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

ECRG Media's Clinical Research Podcast

SEPTEMBER 11, 2018

A german CRO that specializes in Dermatology clinical trials has decided to open an office in North Carolina. Not in the Biotech and clinical research hub of the Raleigh/Durham Triangle but in the coast near Wilmington. Have you heard about ProInnovera before or have an interest in Dermatology?

Dermatology 52

Dermatology Clinical Trials Clinical Trials Clinical Research 52

ECRG Media's Clinical Research Podcast

SEPTEMBER 11, 2018

A german CRO that specializes in Dermatology clinical trials has decided to open an office in North Carolina. Not in the Biotech and clinical research hub of the Raleigh/Durham Triangle but in the coast near Wilmington. Have you heard about ProInnovera before or have an interest in Dermatology?

Dermatology 52

Dermatology Clinical Trials Clinical Trials Clinical Research 52

BioTech 365

OCTOBER 27, 2020

Safety and efficacy data from Phase II clinical trial of nomacopan in adults with mild to moderate BP The Phase II data was the basis for the agreement of the FDA and the EMA that Akari may proceed to a … Continue reading →

Dermatology 40

Dermatology Trials Clinical Trials Clinical Trials 40

BioTech 365

AUGUST 18, 2020

Phase 2b Clinical Trials for Each of the Company’s Lead Assets in Orphan Dermatologic Diseases are Progressing as Planned WOODCLIFF LAKE, NJ, Aug.

Dermatology 40

Dermatology Clinical Trials Clinical Trials Trials 40

Pharmaceutical Technology

FEBRUARY 28, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100